# US 8,278,448 B2 · Technetium and rhenium complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,448 B2
- Document ID: US8278448B2
- Status: Granted
- Kind: B2
- Application number: 13/232,255
- Filed: 2011-09-14
- Published: 2012-03-29
- Granted: 2012-10-02
- Earliest claimed: 2004-10-04
- Assignees: Ge Healthcare Limited
- Inventors: Rajiv Bhalla
- Web page: https://patentgrep.com/patent/US8278448B2

## CPC

- C07F 13/00: Compounds containing elements of Groups 7 or 17 of the Periodic Table
- A61K 51/0476: {complexes from monodendate ligands, e.g. sestamibi}
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the technetium and rhenium complexes of the invention are also provided, as well as radiopharmaceutical compositions comprising said complexes, kits for their preparation. The invention also relates to the use of 99mTc radiopharmaceuticals of the invention for SPECT imaging.

## Claims

### Claim 1

A metal complex of a ligand of Formula I:
wherein:
the metal is a radioactive isotope of either technetium or rhenium;
R1-R3 are independently selected from pyridyl, imidazoyl and pyrazoyl; and,
R4 is —NH(CO)Ph, —NH(CO)(CH2)3—(CO)NHCH2Ph, —NH(CO)(3-pyridyl), —NH(CO)(4-pyridyl), —NH(CO)CH2-piperidinyl, —NH(CO)NH2, or —NH(CO)(2,4-imidazoyl);
and wherein not more than three out of a possible five atoms of the ligand are involved in complexation.

### Claim 2 (depends on 1)

The metal complex of claim 1 wherein R1, R2 and R3 are each pyridyl.

### Claim 3 (depends on 1)

The metal complex of claim 1 wherein R1, R2 and R3 are each 2-pyridyl.

### Claim 4 (depends on 1)

The metal complex of claim 1 wherein the metal is a radioactive isotope of technetium.

### Claim 5 (depends on 4)

The metal complex of claim 4 wherein the radioactive isotope of technetium is 99mTc.

### Claim 6 (depends on 1)

A metal complex of Formula II:
[LMX3]n (II)
wherein:
L is a ligand of Formula I as defined in claim 1;
M is the radioactive isotope of technetium or rhenium;
X is selected from CO, halogen, phosphine, or isonitrile; and,
n is the charge on the metal complex, and is −1, 0, +1 or +2.

### Claim 7 (depends on 1, 6)

The metal complex of claim 6 which is of Formula IIa:
[LM(CO)3]n (IIa)
wherein L is a ligand of Formula I as defined in claim 1, wherein:
R1, R2 and R3 are each 2-pyridyl, and n is +1 or +2.

### Claim 8 (depends on 6)

The metal complex of claim 6 wherein M is a radioactive isotope of technetium.

### Claim 9 (depends on 8)

The metal complex of claim 8 wherein the radioactive isotope of technetium is 99mTc.

### Claim 10

A ligand of Formula I:
wherein:
R1-R3 are independently selected from pyridyl, imidazoyl, and pyrazoyl; and R4 is —NH(CO)Ph, —NH(CO)(CH2)3—(CO)NHCH2Ph, —NH(CO)(3-pyridyl), —NH(CO)(4-pyridyl), —NH(CO)CH2-piperidinyl, —NH(CO)NH2, or —NH(CO)(2,4-imidazoyl).

### Claim 11 (depends on 10)

The ligand of claim 10 wherein R1, R2 and R3 each comprise a 2-pyridyl group.

### Claim 12 (depends on 1)

A radiopharmaceutical comprising the metal complex of claim 1.

### Claim 13 (depends on 12)

A kit for the preparation of the radiopharmaceutical of claim 12 comprising a ligand of Formula I:
wherein:
R1-R3 are independently selected from pyridyl, imidazoyl, and pyrazoyl; and R4 is —NH(CO)Ph, —NH(CO)(CH2)3—(CO)NHCH2Ph, —NH(CO)(3-pyridyl), —NH(CO)(4-pyridyl), —NH(CO)CH2-piperidinyl, —NH(CO)NH2, or —NH(CO)(2,4-imidazoyl).
